Guang Peng

12PUBLICATIONS
72CO-AUTHORS
Molecular targetsRadiation therapyEpigenetics (incl. genome methylation and epigenomics)Ecological impacts of climate change and ecological adaptationPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 27, 2026
Adoptive Cell Therapies for Glioblastoma: A Quest for Cures from Within.

|Mar 08, 2024
GRB2 stabilizes RAD51 at reversed replication forks suppressing genomic instability and innate immunity against cancer.

Zu Ye, Shengfeng Xu, Yin Shi

|Aug 01, 2023
SETD2 Loss and ATR Inhibition Synergize to Promote cGAS Signaling and Immunotherapy Response in Renal Cell Carcinoma.

Xian-De Liu, Yan-Ting Zhang, Daniel J McGrail

|Jul 21, 2023
Targeting polyploid giant cancer cells potentiates a therapeutic response and overcomes resistance to PARP inhibitors in ovarian cancer.

Xudong Zhang, Jun Yao, Xiaoran Li

|Sep 24, 2021
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy.

Guangchun Han, Guoliang Yang, Dapeng Hao

|Aug 05, 2021
GRB2 enforces homology-directed repair initiation by MRE11.

Zu Ye, Shengfeng Xu, Yin Shi

Pageof 2

Frequent Collaborators

3 joint publications

Jaffer Ajani

2 joint publications

John A Tainer

2 joint publications

Linghua Wang

2 joint publications

Zamal Ahmed